Macrophage migration inhibitory factor: Critical role in obesity, insulin resistance, and associated comorbidities

54Citations
Citations of this article
70Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Obesity is associated with insulin resistance, disturbed glucose homeostasis, low grade inflammation, and comorbidities such as type 2 diabetes and cardiovascular disease. The cytokine macrophage migration inhibitory factor (MIF) is an ubiquitously expressed protein that plays a crucial role in many inflammatory and autoimmune disorders. Increasing evidence suggests that MIF also controls metabolic and inflammatory processes underlying the development of metabolic pathologies associated with obesity. This is a comprehensive summary of our current knowledge on the role of MIF in obesity and obesity-associated comorbidities, based on human clinical data as well as animal models of disease. Copyright © 2010 R. Kleemann and R. Bucala.

Cite

CITATION STYLE

APA

Kleemann, R., & Bucala, R. (2010). Macrophage migration inhibitory factor: Critical role in obesity, insulin resistance, and associated comorbidities. Mediators of Inflammation. https://doi.org/10.1155/2010/610479

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free